Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers

Gynecological Endocrinology

Volumn 20, Issue 4, 2005, Pages 221-226

  Mancini, Fulvia ^a   Persico, Nicola ^a   Genazzani, Alessandro D ^b   Volpe, Annibale ^b   Battaglia, Cesare ^a   De Aloysio, Domenico ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Cigarette smoking; Doppler; Hormone replacement therapy; Menopause; Thromboxane

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE ACETATE; THROMBOXANE B2;

ADULT; ARTICLE; BLADDER WALL; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; IMPEDANCE; INTERNAL CAROTID ARTERY; NORMAL HUMAN; OPHTHALMIC ARTERY; PLASMA VISCOSITY; POSTMENOPAUSE; PRIORITY JOURNAL; PULSATILE FLOW; TRANSVAGINAL ECHOGRAPHY; UTERINE ARTERY;

ADMINISTRATION, CUTANEOUS; BLOOD FLOW VELOCITY; BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; ENDOMETRIUM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; EYE; FEMALE; HUMANS; MEDROXYPROGESTERONE; MENOPAUSE; MIDDLE AGED; SMOKING; THROMBOXANE B2; ULTRASONOGRAPHY, DOPPLER; URINARY BLADDER;

EID: 20844461142     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590400027281     Document Type: Article

References (33)

1. Wild RA, Taylor EL, Knehans A. The gynecologist and the prevention of cardiovascular disease. Am J Obstet Gynecol 1995;172:1-13.
2. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking and cardiovascular morbidity in women over 50. The Framingham study. N Engl J Med 1985;313:1038-43.
3. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-33.
4. Sullivan JM, Fowlkers LP. The clinical aspects of estrogen and the cardiovascular system. Obstet Gynecol 1996;87:S36-43.
5. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
6. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991;151:75-8.
7. Mueck AO, Seeger H. Smoking, estradiol metabolism and hormone replacement therapy. Arzneim-Forsch/Drug Res 2003;53:1-11.
8. Geisler J, Omsjø IH, Helle SI, Ekse D, Sisland T, Lønning PE. Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route administration and cigarette smoking. J Endocrinol 1999;162:265-70.
9. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 1986;315:1305-9.
10. Sack MN, Rader DJ, Cannon RO. Estrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:267-70.
11. Roy S. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives. Am J Obstet Gynecol 1999;180:S364-8.
12. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptors. Circulation 1994;89:1943-50.
13. Gordonski GI. Mechanisms of action for estrogen in cardioprotection. In: Wren B, editor. Progress in the management of the menopause. New York: Parthenon; 1997. pp 402-18.
14. Rosenson RS, Tangney CC, Mosca LJ. Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women. Arterioscler Thromb Vasc Biol 1998;18:1902-5.
15. Hillard TC, Bourne TH, Whitehead MI, Crayford TB, Collins WP, Campbell S. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil Steril 1992;58:959-64.
16. Penotti M, Farina M, Sironi L, Barletta L, Gabrielli L, Vignali M. Cerebral artery blood flow in relation to age and menopausal status. Obstet Gynecol 1996;88:106-9
17. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991;338:839-42.
18. Belfort MA, Saade GR, Snabes M, Dunn R, Moise KJ Jr, Cruz A, Young R. Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 1995;172(4 Pt 1):1273-8
19. Kupesic S, Kurjak A, Hajder E. Ultrasonic assessment of the postmenopausal uterus. Maturitas 2002;41:255-67.
20. Nastri MN, Shepherd JH, Setchell ME, Lowe DG, Chard T. Sonographic depiction of postmenopausal endometrium with transabdominal and transvaginal scanning. Ultrasound Obstet Gynecol 1991;1:279-83.
21. Khullar V, Salvatore S, Cardozo L, Bourne TH, Abbott D, Kelleher C. A novel technique for measuring bladder wall thickness in women using transvaginal ultrasound. Ultrasound Obstet Gynecol 1994;4:220-3.
22. Battaglia C, Salvatori M, Giulini S, Primavera MR, Gallinelli A, Volpe A. Hormonal replacement therapy and urinary problems as evaluated by ultrasound and color Doppler. Ultrasound Obstet Gynecol 1999;13:420-4.
23. Battaglia C, Regnani G, Artini PG, Genazzani AR, Primavera MR, Salvatori M, Volpe A. Uterine and cerebral vascularization in postmenopausal women treated with hormone replacement therapy. Gynecol Endocrinol 1999;13:1-7.
24. Battaglia C, Salvatori M, Gallinelli A, Artini PG, Genazzani AR, Volpe A. Color Doppler and hormone replacement therapy: the role of thromboxane and plasma viscosity. Gynecol Endocrinol 1999;13:183-8.
25. Rosano GMC, Sarrel PM, Poole-Wilson PM, Collins P. Beneficial effect of estrogen on exercise induced myocardial ischaemia in women with coronary heart disease. Lancet 1993;342:133-6.
26. Castelli WP. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke. Am J Obstet Gynecol 1999;180:S349-56.
27. Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 1993;22:1159-67.
28. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of estrogen on exercise induced myocardial ischaemia in women with coronary heart disease. Lancet 1993;342:133-6.
29. Bourne T, Hillard TC, Whitehead MI, Crook D, Campbell S. Oestrogens, arterial status, and postmenopausal women. Lancet 1990;335:1470-1.
30. Kerty E, Nyberg-Hansen R, Dahl A, Bakke SJ, Russell D, Rootwelt K. Assessment of the ophthalmic artery as a collateral to the cerebral circulation. A comparison of transorbital Doppler ultrasonography and regional cerebral blood flow measurements. Acta Neurol Scand 1996;93:374-9.
31. Hu HH, Wang S, Chern CM, Yeh HH, Sheng WY, Lo YK. Clinical significance of the ophthalmic artery in carotid artery disease. Acta Neurol Scand 1995;92:242-6.
32. 2 and prostacyclin metabolites in women stratified by age. Circulation 1992;86:1495-500.
33. Failla M, Grappiolo A, Carugo S, Calchera I, Giannattasio C, Mancia G. Effects of cigarette smoking on carotid and radial artery distensibility. J Hypertens 1997;15:1659-64.